Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
This report contains market size and forecasts of Adult Attention Deficit and Hyperactivity Disorder in Global, including the following market information:
Global Adult Attention Deficit and Hyperactivity Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Adult Attention Deficit and Hyperactivity Disorder market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stimulant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Adult Attention Deficit and Hyperactivity Disorder include Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and Noven Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adult Attention Deficit and Hyperactivity Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adult Attention Deficit and Hyperactivity Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Adult Attention Deficit and Hyperactivity Disorder Market Segment Percentages, by Type, 2021 (%)
Stimulant
Non-stimulant
Global Adult Attention Deficit and Hyperactivity Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Adult Attention Deficit and Hyperactivity Disorder Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Adult Attention Deficit and Hyperactivity Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Adult Attention Deficit and Hyperactivity Disorder Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adult Attention Deficit and Hyperactivity Disorder revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Adult Attention Deficit and Hyperactivity Disorder revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma